Skip to main content
Skip to content
Case File
sd-10-EFTA01461635Dept. of JusticeOther

EFTA Document EFTA01461635

From: Tazia Smith Inelmeefletbelbeemal Sent: 5/8/2014 2:23:51 PM To: [email protected] CC: Nay GuptaISINI ); Paul Morris [ Vahe Stepanian Vinit Sahni Subject: Re: Biotech Update... IC] Classification: Confidential Jeffrey - Updating you on your biotech basket because most of the names are struggling to rebound from the recent rotational sell- off, exception is GILD which has good valuation support, showed a strong earnings beat, and is back up to —$79.36 (your avg cost is $79.

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01461635
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

From: Tazia Smith Inelmeefletbelbeemal Sent: 5/8/2014 2:23:51 PM To: [email protected] CC: Nay GuptaISINI ); Paul Morris [ Vahe Stepanian Vinit Sahni Subject: Re: Biotech Update... IC] Classification: Confidential Jeffrey - Updating you on your biotech basket because most of the names are struggling to rebound from the recent rotational sell- off, exception is GILD which has good valuation support, showed a strong earnings beat, and is back up to —$79.36 (your avg cost is $79.

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Tazia Smith Inelmeefletbelbeemal Sent: 5/8/2014 2:23:51 PM To: [email protected] CC: Nay GuptaISINI ); Paul Morris [ Vahe Stepanian Vinit Sahni Subject: Re: Biotech Update... IC] Classification: Confidential Jeffrey - Updating you on your biotech basket because most of the names are struggling to rebound from the recent rotational sell- off, exception is GILD which has good valuation support, showed a strong earnings beat, and is back up to —$79.36 (your avg cost is $79.41). FMI reported earnings after the close yesterday, which were inline but guidance was on the low end. Stock has sold off 15% (down to —$24 currently from from a high of $30 yesterday). Please find your updated PIL below. Included SGMO chart - that company reported a moderately better quarter on Tuesday evening, hence the 3% uptick and several positive reports from the competitors across the Street. At a 3/11/14 2:10pm Desalt:Mon Trade Data QintilUtT Currant Pike Unit Cost Market Value Current Taal Cast Unrealised G/L SANGAIIO 810SCIENCE.S 5/28/2013 50,000.00 $ 12.1.7 $ 8.44 $ 603,500.00 422,214.00 S 186,286.00 !MOGEN 2/14/2012 2,095.00 6 235.23 5 119.53 $ 597,661.60 250,454.93 6 347,236 65 FOUNDATION ativiang 1/13/2014 25,000.00 $ 24.1.3 $ 27.51 $ 603,250.00 687,663.50 $ (54,413.50) GILEAD SCIENCES INC Multiple 8,100,00 $ 79.36 6 79.41 $ 642.816,00 543,204.80 $ (383.00) Total Masa 2,453,317.60 3,003,536.45 $ 440,691.35 ARNO PHARMACEUTICALS Multiple 16,535,00 $ 6.76 6 17.60 $ 111,775.60 290,997,40 $ (179,220,50) Px_LAsT Source: Bloomberg and Pershing LLC as of 5/8/14 SGMO US 012.05 12.06 8 .4 A- 14:12 _1.80C H 12.72 -r L 11.7501 9.237M 99 Save A.5 9at Actions Q Edit - Table 05/09/1013 Us: Once " =a" cc,-, are MUM MI it 3D 94 am YTD Line Chart 1T' iY va , a d. }'_.ry Evrt 4- Track L. Annotate News , Zoom 1 ill Last Price 12.05 T High on 03/19/14 23.86 -0- Average 12.7832 1. Low on 06/26/13 7.31 24.00 22.00 20.00 18.00 16.00 14.00 10.00 8.00 II Volume 0.747M 10M 1 • SMAI (15) 1.015M SM taLaiLusaaalLhaseak.Agaua.atakballia‘saiaaiguaauwAstadowahoressagaimak lamikketialftlei Jun Sep Dec Mar 2013 2014 CONFIDENTIAL — PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0 123788 SDNY_GM_00269972 EFTA01461635

Technical Artifacts (1)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Related Documents (6)

Dept. of JusticeOtherUnknown

EFTA Document EFTA01461624

From: Tazia Smith Sent: 5/8/2014 2:23:S0 PM To: jeevacation@ mail.com CC: Nay Gupta ; Paul Moa; Vinit Sahn Subject: Re: Biotech Update... (C) Attachments: pic03979.gif; pic18499.gif; pic14904.gif; pic06061.gif; pic03646.gif; pic17133.gif; pic19498.gif; pic10560.gif; pic07051.gif; pic03128.gif Vahe Stepanian classification: confidential Jeffrey - updating you on your biotech basket because most of the names are struggling to rebound from the recent rotational sell-off, exception is

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01469245

Subject: Re: Banco Espirito continued From: Nav Gupta .ffi Date: Tue, 01 Jul 2014 10:39:04 -0400 To: Cc: Paul Morris Vinit Sahni Tazia Smith Classification: Confidential Banco Espirito has 3 issues 1. it is in trouble with regulators after it funded its cash position by issuing bills and bonds to retail and institutional clients who has entrusted funds to the bank on a discretionary basis.market participants worry about the firms ability to raise capital. 2. it has a large exposure

16p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01467440

Subject: RE: Energy Renaissance E uities + Trade idea: KI Brent puts [C) From: Tazia Smith < Date: Mon, 03 Mar 2014 14:32:52 -0500 To: Cc: Paul Morris Vahe Stepanian < Classification: Confidential Yes, will do - thanks Jeanne! (Embedded image moved to file: pic26026.gif) Tazia Smith Director I Key Client Partners - US Deutsche Deutsche 345 Park New York Tel. Fax Mobile Email Bank Securities Inc Asset & Wealth Management Avenue, 26th Floor NY 10154 (Embedded From: To: C

4p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01447254

From: Tazia Smit Sent: 5/8/2014 2:23:50 PM To: [email protected] CC: Nay Gupta Maaul Morris Vinit Sahni Subject: Re: Biotech Update... (C) Attachments: pic02547.gif; pic14310.gif; pic18758.gif; pic08428.gif; pic07767.gif; pic25070.gif; pic18644.gif; pic03988.gif; pic22440.gif; pic15968.gif Vahe Stepanian classification: confidential Jeffrey - updating you on your biotech basket because most of the names are struggling to rebound from the recent rotational sell-off, exception

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01479583

Subject: Re: Biotech Update... [C] From: Tazia Smith ‹ > Date: Thu, 08 May 2014 14:23:51 -0400 To: [email protected] Cc: Nav Gupta Paul Morris Vahe Stepanian Vinit Sahni Classification: Confidential Jeffrey - Updating you on your biotech basket because most of the names are struggling to rebound from the recent rotational sell-off, exception is GILD which has good valuation support, showed a strong earnings beat, and is back up to —$79.36 (your avg cost is $79.41). FMI reported

3p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01462626

Subject: Fw: Consider: $10-15mm Total Return Swap on Cash Return On Capital Invested (CROCI), 3mL+85 bps or relative value TRS vs S&P.... [C] From: Tazia Smith Date: Thu, 15 May 2014 15:51:48 -0400 To: eevacation mail.com Cc: Paul Morris < Vahe Stepanian Vinit Sahni < Nav Gupta < Classification: Confidential Jeffrey - Our global colleagues are re-highlighting the CROCI solution at current levels and/or for outperform ance in this rotational environment. sending their commentary and r

4p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.